EMEIS SA (ORP.PA) Stock Fundamental Analysis
Europe - EPA:ORP - FR001400NLM4 - Common Stock
12.465 EUR
+0.15 (+1.24%)
Taking everything into account, ORP scores 4 out of 10 in our fundamental rating. ORP was compared to 30 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ORP while its profitability can be described as average. ORP is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year ORP was profitable.
In the past year ORP had a positive cash flow from operations.
ORP had positive earnings in 4 of the past 5 years.
ORP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ORP has a Return On Assets of 9.74%. This is amongst the best in the industry. ORP outperforms 100.00% of its industry peers.
ORP has a Return On Equity of 71.82%. This is amongst the best in the industry. ORP outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.74% | ||
| ROE | 71.82% | ||
| ROIC | N/A |
ROA(3y)-5.89%
ROA(5y)-3.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ORP has a Profit Margin of 26.07%. This is amongst the best in the industry. ORP outperforms 100.00% of its industry peers.
ORP's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for ORP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 26.07% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y32.24%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ORP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ORP has been reduced compared to 1 year ago.
The number of shares outstanding for ORP has been reduced compared to 5 years ago.
ORP has a better debt/assets ratio than last year.
2.2 Solvency
ORP has an Altman-Z score of 0.39. This is a bad value and indicates that ORP is not financially healthy and even has some risk of bankruptcy.
ORP has a Altman-Z score of 0.39. This is amonst the worse of the industry: ORP underperforms 85.71% of its industry peers.
ORP has a Debt/Equity ratio of 4.30. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ORP (4.30) is worse than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.3 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.39 |
ROIC/WACCN/A
WACC5.23%
2.3 Liquidity
A Current Ratio of 0.60 indicates that ORP may have some problems paying its short term obligations.
ORP has a worse Current ratio (0.60) than 85.71% of its industry peers.
ORP has a Quick Ratio of 0.60. This is a bad value and indicates that ORP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.60, ORP is doing worse than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 360.39% over the past year.
ORP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 116.08% yearly.
The Revenue has grown by 11.04% in the past year. This is quite good.
ORP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.73% yearly.
EPS 1Y (TTM)360.39%
EPS 3Y301.6%
EPS 5Y116.08%
EPS Q2Q%278.1%
Revenue 1Y (TTM)11.04%
Revenue growth 3Y9.84%
Revenue growth 5Y8.73%
Sales Q2Q%11.4%
3.2 Future
Based on estimates for the next years, ORP will show a very strong growth in Earnings Per Share. The EPS will grow by 26.14% on average per year.
Based on estimates for the next years, ORP will show a quite strong growth in Revenue. The Revenue will grow by 8.11% on average per year.
EPS Next Y99.7%
EPS Next 2Y41.51%
EPS Next 3Y26.14%
EPS Next 5YN/A
Revenue Next Year6.41%
Revenue Next 2Y9.12%
Revenue Next 3Y8.11%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 1.20 indicates a rather cheap valuation of ORP.
ORP's Price/Earnings ratio is rather cheap when compared to the industry. ORP is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of ORP to the average of the S&P500 Index (26.35), we can say ORP is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for ORP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.2 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ORP's earnings are expected to grow with 26.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)0.01
EPS Next 2Y41.51%
EPS Next 3Y26.14%
5. Dividend
5.1 Amount
No dividends for ORP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.98B
Revenue(TTM)5.20B
Net Income(TTM)1.35B
Analysts48.89
Price Target170.74 (1269.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-24.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)98.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.2 | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | N/A | ||
| P/OCF | 5.42 | ||
| P/B | 1.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)10.36
EY83.11%
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)2.3
OCFY18.45%
SpS32.65
BVpS11.85
TBVpS-6.36
PEG (NY)0.01
PEG (5Y)0.01
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.74% | ||
| ROE | 71.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 26.07% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-5.89%
ROA(5y)-3.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y32.24%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.3 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.39 |
F-Score6
WACC5.23%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.91%
Cap/Sales(5y)16.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)360.39%
EPS 3Y301.6%
EPS 5Y116.08%
EPS Q2Q%278.1%
EPS Next Y99.7%
EPS Next 2Y41.51%
EPS Next 3Y26.14%
EPS Next 5YN/A
Revenue 1Y (TTM)11.04%
Revenue growth 3Y9.84%
Revenue growth 5Y8.73%
Sales Q2Q%11.4%
Revenue Next Year6.41%
Revenue Next 2Y9.12%
Revenue Next 3Y8.11%
Revenue Next 5YN/A
EBIT growth 1Y81.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.08%
EBIT Next 3Y32.13%
EBIT Next 5YN/A
FCF growth 1Y-135.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.64%
OCF growth 3Y-22.21%
OCF growth 5Y-2.48%
EMEIS SA / ORP.PA FAQ
Can you provide the ChartMill fundamental rating for EMEIS SA?
ChartMill assigns a fundamental rating of 4 / 10 to ORP.PA.
Can you provide the valuation status for EMEIS SA?
ChartMill assigns a valuation rating of 4 / 10 to EMEIS SA (ORP.PA). This can be considered as Fairly Valued.
How profitable is EMEIS SA (ORP.PA) stock?
EMEIS SA (ORP.PA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of EMEIS SA (ORP.PA) stock?
The Price/Earnings (PE) ratio for EMEIS SA (ORP.PA) is 1.2 and the Price/Book (PB) ratio is 1.05.
Is the dividend of EMEIS SA sustainable?
The dividend rating of EMEIS SA (ORP.PA) is 0 / 10 and the dividend payout ratio is 0%.